RT by @EIB: 🇪🇺 The @EIB signed today a venture debt investment in @LUMICKS_nl, a leading med-tech innovator focused on improving success rates in clinical trials for immunotherapy & cell therapy against cancer.

Proud to support Europe’s R&D champions in frontier health technologies!
👏🏼👏🏼👏🏼

[2024-10-10 13:05 UTC]